Last reviewed · How we verify

NCT03311347

Atelectasis Formation: Role of Positive Pressure Breathing, Hyperoxia, and Hypobaria

Status unknown NA Last updated 14 May 2019
What this trial tests

NA trial testing +Gz accelerations and positive pressure breathing in Pulmonary Atelectasis in 80 participants. Status unknown.

Timeline
14 September 2015
Primary endpoint
30 June 2019
1 January 2020

Quick facts

Lead sponsorDirection Centrale du Service de Santé des Armées
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment80
Start date14 September 2015
Primary completion30 June 2019
Estimated completion1 January 2020
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Direction Centrale du Service de Santé des Armées — full company profile →

Who can join

Adults 25 to 45, male only, with Pulmonary Atelectasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this project is to get further knowledge of the physiology of flight atelectasis and its prevention. We seek to: 1) assess whether low levels of positive pressure breathing can prevent atelectasis formation in humans during exposure to hyperoxia and +Gz-accelerations. 2) get further knowledge on the effects of hypobaria on regional ventilation and perfusion. A secondary aim is to evaluate the effect of anti G-trouser inflation on ventilation and regional perfusion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pulmonary Atelectasis

Currently open trials in the same condition.

Other Direction Centrale du Service de Santé des Armées trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03311347.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing